Fentanyl adulterated or associated with xylazine implementation report.

Bibliographic Details
Corporate Authors:	United States. Office of National Drug Control Policy (Author), United States. Congress. House. Committee on Appropriations, United States. Congress. House. Committee on Oversight and Accountability, United States. Congress. House. Committee on Energy and Commerce, United States. Congress. House. Committee on the Judiciary, United States. Congress. Senate. Committee on Appropriations, United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, United States. Congress. Senate. Committee on the Judiciary
Format:	Government Document Serial
Language:	English
Published:	Washington, D.C. : The White House, Executive Office of the President, Office of National Drug Control Policy, 2024-
Subjects:	Fentanyl > United States. Xylazine > United States. Drug abuse > United States. Drug control > United States. Drug traffic > United States. Drug utilization > United States. Drug trafficking and controlled substances. Drug, alcohol, tobacco use. Health promotion and preventive care. Mental health. Smuggling and trafficking. Annual reports.
Online Access:	Available from GovInfo Available from ONDCP

Available Online